Finance

Lists
Why is PVCT down 4.73%?
Dive Deeper
PVCT:OTCMKTS
Provectus Biopharmaceuticals Inc
$0.054
-4.73%
(-0.0027) 1D
Oct 1, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PVCT...
Open
$0.05
High
$0.05
Low
$0.05
Mkt. cap
21.76M
Avg. vol.
128.26K
Volume
425.78K
52-wk high
$0.09
52-wk low
$0.04
EPS
-$0.01
Beta
0.86
Shares outstanding
420.28M
No. of employees
6
Open
$0.05
High
$0.05
Low
$0.05
Mkt. cap
21.76M
Avg. vol.
128.26K
Volume
425.78K
52-wk high
$0.09
52-wk low
$0.04
EPS
-$0.01
Beta
0.86
Shares outstanding
420.28M
No. of employees
6
News stories
From web sources and news partners
About Provectus Biopharmaceuticals Inc
CEO-
Employees6
Founded2002
HeadquartersKnoxville, Tennessee, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
-
-
-
-
Cost of goods sold
323.22K
248.94K
324.27K
121.55K
Cost of revenue
323.22K
248.94K
324.27K
121.55K
Research and development expenses
13.64K
13.64K
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
831.08K
761.24K
923.63K
737.40K
Operating expense
844.72K
774.88K
923.63K
737.40K
Total operating expenses
1.17M
1.02M
1.25M
858.95K
Operating income
-1.17M
-1.02M
-1.25M
-858.95K
Other non operating income
-
-
-
-
EBT including unusual items
-1.32M
-1.17M
-1.30M
-988.72K
EBT excluding unusual items
-1.22M
-1.07M
-1.30M
-909.27K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.31M
-1.17M
-1.29M
-982.57K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-48.02K
-47.32K
-53.05K
-50.32K
Net interest expenses
-48.02K
-47.32K
-53.05K
-50.32K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.17M
-1.02M
-1.25M
-858.48K
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps